Type 2 Diabetes Clinical Trials Database - Free Access to 1,397 Studies
Access comprehensive clinical trial information for Type 2 Diabetes through Pure Global AI's free database. This collection includes 1,397 clinical trials across multiple phases including N/A, Phase 3, Phase 4. Currently, 195 trials are actively recruiting participants.
Research for Type 2 Diabetes is being conducted in United States of America, China, Japan and 7+ other countries. Leading sponsors include AstraZeneca and Eli Lilly and Company. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Effect of Linking Data Using Smartphone Application, 'Well Check', on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus
Evaluation of Efficacy and Safety of Combination Therapy of Henagliflozin Proline, Retagliptin and Metformin in New Diagnosed Type 2 Diabetes Patients
Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i.
Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis
The Acute Effect of Exercise Snacks on Glycemic Responses in Individuals With Type 2 Diabetes.
The Acute Effect of Low-intensity Movement Breaks on Glycemic Responses in Individuals With Type 2 Diabetes.
Efficacy of Exercise Snacks in Real-World Settings in Individuals Living With Type 2 Diabetes
Continuous Glucose Monitoring, Contingency Management, and Motivational Interviewing for Patients With Type 2 Diabetes in Kansas City
Effects of Using Decision Cycle for Person-Centered Glycemic Management in Type 2 Diabetes
Salivary Signal Molecules for Neural and Vascular Homeostasis in T2DM
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin
Implementing an Effective Diabetes Intervention Among Low-Income Immigrants
Leveraging Videos and Community Health Workers to Address Social Determinants of Health in Immigrants
The Effect of a Ketone Drink on Blood Glucose Levels in People With Type 2 Diabetes
The Impact of Oral Glutathione on Oxidative Damage and Glycated Hemoglobin (HbA1c) Levels in Type 2 Diabetes Patients
Remotely Delivered Mindfulness-Based Diabetes Education
Risk of CKD in Diabetic Patients With MAFLD
Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)
Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
Pure Global AI provides free access to 1,397 clinical trials studying Type 2 Diabetes, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include AstraZeneca, Eli Lilly and Company, Jiangsu HengRui Medicine Co., Ltd., among others.

